Alzheimer’s Disease Treatment With Flashing Light Is Big New Hope

Alzheimer’S Disease Treatment With Flashing Light

Alzheimer’s disease is one of the biggest unanswered questions in medicine.Five million Americans are currently estimated to have the mind-ravaging disease, a number expected to triple by 2050 without effective interventions. But the track record in drug that halts mental decline for Alzheimer’s Disease Treatment development has been terrible: a success rate of less than 1 percent.

“Already 1 of $5 of Medicare and Medicaid goes to Alzheimer’s,” said Rudy Tanzi, director of the genetics and aging Alzheimer’s disease research unit at Massachusetts General Hospital and a professor of neurology at Harvard Medical School.“As 71 million Baby Boomers like I head toward risk age, it will go into 1 of $3 or 1 of $2, and Alzheimer’s will single-handedly collapse our health-care system. It will single-handedly collapse Medicare and Medicaid in this country.”The need for Alzheimer’s disease treatment stands in stark contrast to science’s understanding of the disease.


LEAVE A REPLY

Please enter your comment!
Please enter your name here